Westchester Capital Management (New York)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Westchester Capital Management (New York)’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-253,848	Closed	-$55.1M	–	399
2021 Q1	$55.1M	Buy	+253,848	New	+$47.7M	1.52%	17

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Westchester Capital Management (New York)'s GWPH Position: Q2 2021 in Review

Westchester Capital Management (New York) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 253,848 shares — an estimated $55.1M sold.

Westchester Capital Management (New York) first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $55.1M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Westchester Capital Management (New York) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Westchester Capital Management (New York) sold 253,848 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $55.1M.
Westchester Capital Management (New York) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Westchester Capital Management (New York)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $55.1M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2021, filed 13 Aug 2021.